96 related articles for article (PubMed ID: 127459)
1. The effect of antibody and complement on perfused hearts: a model for the study of xenograft rejection phenomenon.
Pinto ME; Nelson RA
Z Immunitatsforsch Exp Klin Immunol; 1975 May; 149(1):78-93. PubMed ID: 127459
[TBL] [Abstract][Full Text] [Related]
2. Delayed rejection of cardiac xenografts in C6-deficient rabbits.
O'Regan CC; Robitaille P; Pinto-Blonde M; Chartrand C
Immunology; 1979 Oct; 38(2):245-8. PubMed ID: 389781
[TBL] [Abstract][Full Text] [Related]
3. Activation of the alternative pathway of complement in hyperacute xenograft rejection of rabbit hearts by human blood.
Forty J; White DJ; Wallwork J
J Heart Lung Transplant; 1993; 12(2):283-6; discussion 286-7. PubMed ID: 8476902
[TBL] [Abstract][Full Text] [Related]
4. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
[TBL] [Abstract][Full Text] [Related]
5. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection.
Kroshus TJ; Dalmasso AP; Leventhal JR; John R; Matas AJ; Bolman RM
J Surg Res; 1995 Jul; 59(1):43-50. PubMed ID: 7630135
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neutrophil adhesion and the membrane attack complex of complement synergistically prolongs cardiac xenograft survival.
Davis EA; Lam TT; Qian Z; Ibrahim S; Baldwin WM; Sanfilippo FP
J Heart Lung Transplant; 1995; 14(5):973-80. PubMed ID: 8800736
[TBL] [Abstract][Full Text] [Related]
7. Prolonged discordant xenograft survival by inhibition of the intrinsic coagulation pathway in complement C6-deficient recipients.
Jakobs FM; Davis EA; White T; Sanfilippo F; Baldwin WM
J Heart Lung Transplant; 1998 Mar; 17(3):306-11. PubMed ID: 9563608
[TBL] [Abstract][Full Text] [Related]
8. Dominant role of complement in the hyperacute xenograft rejection reaction.
Schilling A; Land W; Pratschke E; Pielsticker K; Brendel W
Surg Gynecol Obstet; 1976 Jan; 142(1):29-32. PubMed ID: 1105839
[TBL] [Abstract][Full Text] [Related]
9. A novel recombinant fibrinogenase of Agkistrodon acutus venom protects against hyperacute rejection via degradation of complements.
Lin X; Qi JZ; Chen MH; Qiu BT; Huang ZH; Qiu PX; Chen JS; Yan GM
Biochem Pharmacol; 2013 Mar; 85(6):772-9. PubMed ID: 23178656
[TBL] [Abstract][Full Text] [Related]
10. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model.
Lexer G; Cooper DK; Rose AG; Wicomb WN; Rees J; Keraan M; Du Toit E
J Heart Transplant; 1986; 5(6):411-8. PubMed ID: 3302173
[TBL] [Abstract][Full Text] [Related]
11. Use of a novel CD11b/CD18 inhibitory agent in a C6-deficient rat to evaluate delayed xenograft rejection.
Johnson E; Leventhal J; Dalmasso A; Goswitz J; Simone P; Chen S; Moyle M; Matas A
Transplant Proc; 1996 Apr; 28(2):728. PubMed ID: 8623367
[No Abstract] [Full Text] [Related]
12. The role of CD11b/CD18 mediated neutrophil adhesion in complement deficient xenograft recipients.
Jakobs FM; Davis EA; Qian Z; Liu DY; Baldwin WM; Sanfilippo F
Clin Transplant; 1997 Oct; 11(5 Pt 2):516-21. PubMed ID: 9361953
[TBL] [Abstract][Full Text] [Related]
13. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of C3 and C5 prolongs cardiac xenograft survival and decreases leukocyte infiltration in a model of delayed xenograft rejection.
Johnson EM; Leventhal J; Dalmasso AP; Goswitz J; Simone P; Chen S; Matas AJ
Transplant Proc; 1996 Apr; 28(2):603. PubMed ID: 8623296
[No Abstract] [Full Text] [Related]
15. Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
Brandl U; Jöckle H; Erhardt M; Michel S; Burdorf L; Brenner P; Bittmann I; Rössle M; Mordstein V; Hammer C; Thein E; Reichart B; Schmoeckel M
Transplantation; 2007 Dec; 84(12):1667-76. PubMed ID: 18165780
[TBL] [Abstract][Full Text] [Related]
16. Soluble Galalpha(1,3)Gal conjugate combined with hDAF preserves morphology and improves function of cardiac xenografts.
Brandl U; Erhardt M; Michel S; Jöckle H; Burdorf L; Bittmann I; Rössle M; Mordstein V; Brenner P; Hammer C; Reichart B; Schmoeckel M
Xenotransplantation; 2007 Jul; 14(4):323-32. PubMed ID: 17669174
[TBL] [Abstract][Full Text] [Related]
17. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.
Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH
J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell- and macrophage mediated discordant guinea pig-->rat xenograft rejection in the absence of complement, xenoantibody and T cell immunity.
Xia G; Ji P; Rutgeerts O; Waer M
Transplantation; 2000 Jul; 70(1):86-93. PubMed ID: 10919580
[TBL] [Abstract][Full Text] [Related]
19. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts.
Brauer RB; Baldwin WM; Daha MR; Pruitt SK; Sanfilippo F
J Immunol; 1993 Dec; 151(12):7240-8. PubMed ID: 8258722
[TBL] [Abstract][Full Text] [Related]
20. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
